42.60
Tectonic Therapeutic Inc Stock (TECX) Latest News
Petri Dish: VC firm's new $340M seed fund; Watertown biotech raises $185M - The Business Journals
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $80.50 - Defense World
Tectonic announces ~$185M capital raise - MSN
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 3.2%Here's Why - MarketBeat
Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data (NASDAQ:TECX) - Seeking Alpha
Tectonic secures $185 million in private equity funding - MSN
Tectonic Therapeutic (NASDAQ:TECX) Given New $112.00 Price Target at Wells Fargo & Company - MarketBeat
TECX (Tectonic Therapeutic Inc) may reap gains as insiders became active recently - Knox Daily
Tectonic Therapeutic (NASDAQ:TECX) Trading 6.7% Higher After Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 52-Week HighTime to Buy? - MarketBeat
Tectonic Therapeutic to Raise $185 Million Via Private Investment in Public Equity Financing - Marketscreener.com
Tectonic Therapeutic Secures $185 Million in PIPE Deal - TipRanks
Tectonic Therapeutic announces $185M private placement - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Tectonic Announces $185 Million Private Placement - The Bakersfield Californian
Major Funding Alert: Tectonic Therapeutic Lands $185M from Elite Investors at Premium Price - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $112.00 - Defense World
Tectonic Therapeutic reports ‘positive’ data from Phase 1b trial for TX45 - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 13.3%Should You Sell? - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 13.3%Here's What Happened - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Up 6.7% on Analyst Upgrade - Defense World
Tectonic jumps on positive data from early-stage trial for lead asset - MSN
Wall Street Rally: Dow Hits One-Month High as IBM Surges, Microsoft Declines – Market - HPBL
Tectonic’s Plates Shift On Positive Phase Ib PH-HFpEF Data - News & Insights
Wall Street relaxin as Tectonic plates up phase Ib heart data - BioWorld Online
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Tectonic Therapeutic: Stock Spikes On Heart Failure Data — Why I See Further Upside (TECX) - Seeking Alpha
Stock market news: Foxx Development Holdings +220.76%, Tectonic Therapeutic +117.03% among top gainers during mid day trading - Business Upturn
Tectonic Therapeutic Shares Hit 52-Week High After Positive Trial Data - MarketWatch
Tectonic Therapeutic (TECX) Stock Soars On Positive Clinical Trial Update - Stocks Telegraph
Stock market today: Foxx Development Holdings +243.94%, Alpha Modus Holdings +142.21% among top gainers in early trading - Business Upturn
Dow Jumps Over 100 Points; Tesla Earnings Miss Views - Benzinga
Tectonic Therapeutic Shares Soar Pre-Bell Following Interim Data From TX45 Trial -January 30, 2025 at 09:20 am EST - Marketscreener.com
Tectonic stock jumps on trial data for TX45 (TECX:NASDAQ) - Seeking Alpha
Tectonic Therapeutic stock soars on positive trial data By Investing.com - Investing.com Canada
Tectonic Therapeutic stock soars on positive trial data - Investing.com
Tectonic Therapeutic Reports Positive Interim Results for TX45 - TipRanks
Tectonic Therapeutic Announces Positive Interim Data from - GlobeNewswire
Game-Changing Results: This New Drug Could Transform Pulmonary Hypertension Treatment - StockTitan
Eli Lilly trial update on kidney drug hurts Tectonic - MSN
Tectonic stock plunges on Eli Lilly trial update (TECX:NASDAQ) - Seeking Alpha
Leerink says Eli Lilly news causes concern about Tectonic’s TX45 success - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Shares Up 8.2%Here's What Happened - MarketBeat
Clarius Group LLC Invests $468,000 in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic Highlights Pipeline and Financial Strength - TipRanks
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Price Target at $72.25 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 8.8%Should You Sell? - MarketBeat
We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth - Simply Wall St
AVROBIO, Inc. Announces Acceptance of Investigational New Drug Application for Investigator-Sponsored Phase 1/2 Clinical Trial for AVR-RD-04 Gene Therapy for Cystinosis - Marketscreener.com
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):